首页> 美国卫生研究院文献>Clinical and Developmental Immunology >The Role of Chemokines in Breast Cancer Pathology and Its Possible Use as Therapeutic Targets
【2h】

The Role of Chemokines in Breast Cancer Pathology and Its Possible Use as Therapeutic Targets

机译:趋化因子在乳腺癌病理学中的作用及其作为治疗靶点的可能用途

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Chemokines are small proteins that primarily regulate the traffic of leukocytes under homeostatic conditions and during specific immune responses. The chemokine-chemokine receptor system comprises almost 50 chemokines and approximately 20 chemokine receptors; thus, there is no unique ligand for each receptor and the binding of different chemokines to the same receptor might have disparate effects. Complicating the system further, these effects depend on the cellular milieu. In cancer, although chemokines are associated primarily with the generation of a protumoral microenvironment and organ-directed metastasis, they also mediate other phenomena related to disease progression, such as angiogenesis and even chemoresistance. Therefore, the chemokine system is becoming a target in cancer therapeutics. We review the emerging data and correlations between chemokines/chemokine receptors and breast cancer, their implications in cancer progression, and possible therapeutic strategies that exploit the chemokine system.
机译:趋化因子是小的蛋白质,主要在稳态条件下和特定的免疫应答过程中调节白细胞的运输。趋化因子-趋化因子受体系统包含近50个趋化因子和约20个趋化因子受体。因此,每种受体没有独特的配体,不同趋化因子与同一受体的结合可能产生不同的作用。这些作用进一步使系统复杂化,取决于细胞环境。在癌症中,尽管趋化因子主要与肿瘤微环境的产生和器官定向转移有关,但它们还介导与疾病进展相关的其他现象,例如血管生成,甚至化学耐药性。因此,趋化因子系统正成为癌症治疗中的靶标。我们审查了趋化因子/趋化因子受体与乳腺癌之间的新兴数据及其相关性,它们对癌症进展的影响,以及利用趋化因子系统的可能治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号